Sarcomas of the head and neck region

Current Oncology Reports

Volumn 11, Issue 2, 2009, Pages 135-142

  Shellenberger, Thomas D ^b   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; GEMCITABINE; IDOXURIDINE; IFOSFAMIDE; RAZOXANE; VINCRISTINE;

ADJUVANT THERAPY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FOLLOW UP; HEAD AND NECK SARCOMA; HEAD AND NECK SURGERY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SARCOMA; SOFT TISSUE SARCOMA;

HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; PROGNOSIS; SARCOMA;

EID: 60349126507     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-009-0020-8     Document Type: Review

References (51)

1. DeVita VT Jr, Hellman S, Rosenberg SA: Sarcomas of the soft tissues and bone. In Cancer: Principles and Practice of Oncology, edn 6. Edited by DeVita VT Jr, Hellman S, Rosenberg SA. Philadelphia: Lippincott Williams and Wilkins; 2005:1841-1891.
2. Lawrence W Jr, Anderson JR, Gehan EA, et al.: Pretreatment TNM staging of childhood rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer 1997, 80:1165-1170.
3. Weber RS, Benjamin RS, Peters LJ, et al.: Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 1986, 152:386-392.
4. McClay EF: Epidemiology of bone and soft tissue sarcomas. Semin Oncol 1989, 16:264-272.
5. Potter BO, Sturgis EM: Sarcomas of the head and neck. Surg Oncol Clin N Am 2003, 12:379-417.
6. O'Sullivan B, Audet N, Catton C, et al.: Soft tissue and bone sarcomas of the head and neck. In Head and Neck Cancer: A Multidisciplinary Approach, edn 2. Edited by Harrison LB, Sessions RB, Hong WK. Philadelphia: Lippincott Williams and Wilkins; 2003:786-824.
7. Meyers PT, Schwartz CL, Krailo MD, et al.: Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival - a report from the Children's Oncology Group. J Clin Oncol 2008, 26:633-638.
8. DiResta GR, Aiken SW, Brown HK, et al.: Influence of carboplatin infusion on osteosarcoma blood flow. Cancer Chemother Pharmacol 2008, 62:545-549.
9. DiResta GR, Aiken SW, Brown HK, et al.: Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response. Ann Surg Oncol 2007, 14:2411-2421.
10. Lewis IJ, Nooij MA, Whelan J, et al.: Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007, 99:112-128.
11. Le DeAey M-C, Guinebretiere J-M, Genet J-C, et al.: SFOP OS94: a randomized trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcomas patients. Eur J Cancer 2007, 43:752-761.
12. Enzinger FM: Malignant fibrous histiocytoma 20 years after Stout. Am J Surg Pathol 1986, 10(Suppl 1):43-53.
13. Lydiatt WM, Shaha AR, Shah JP: Angiosarcoma of the head and neck. Am J Surg 1994, 168:451-454.
14. Morrison WH, Byers RM, Garden AS, et al.: Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer 1995, 76: 319-327.
15. Mark RJ, Tran LM, Sercarz J, et al.: Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993, 119:973-978.
16. Loos BM, Wieneke JA, Thompson LD: Laryngeal angiosarcoma: a clinicopathologic study of five cases with a review of the literature. Laryngoscope 2001, 111:1197-1202.
17. Aust MR, Olsen KD, Lewis JE, et al.: Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol 1997, 106:943-951.
18. Callender TA, Weber RS, Janjan N, et al.: Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 1995, 112:252-257.
19. Nayar RC, Prudhomme F, Parise O, et al.: Rhabdomyosarcoma of the head and neck in adults: A study of 26 patients. Laryngoscope 1993, 103:1362-1366.
20. Kraus DH, Saenz NC, Gollamudi S, et al.: Pediatric rhabdomyosarcoma of the head and neck. Am J Surg 1997, 174:556-560.
21. Anderson GJ, Toth GK, Gibbons WA: Protein engineering of the IgE receptor and its subunits by solid-phase synthesis and spectroscopy. Biochem Soc Trans 1990, 10:1306-1307.
22. Feldman BA: Rhabdomyosarcoma of the head and neck. Laryngoscope 1982, 92:424-440.
23. Burke M, Anderson JA, Kao SC, et al.: Assessment of response to induction therapy and its influence of 5-year failure-free survival in group III rhabdomyosarcoma: The Intergroup Rhabdomyosarcoma Study-IV experience - a report from the soft tissue sarcoma committee of the Children's Oncology Group. J Clin Oncol 2007, 25: 4909-4913.
24. Oberlin O, Rey A, Lyden E, et al.: Prognostic factors in metastatic rhabdomyosarcomas: Results of pooled analysis from United States and European Cooperative Groups. J Clin Oncol 2008, 26:2384-2389.
25. Arndt CA, Hawkins DS, Meyer WH, et al.: Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2008, 50: 33-36.
26. Green FL, Page DL, Flemming FD, et al.: Soft tissue sarcoma. In American Joint Committee on Cancer: Cancer Staging Manual, edn 6. Edited by Page DL. New York: Springer; 2002: 221-226.
27. LeVay J, O'Sullivan B, Catton C, et al.: Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993, 27:1091-1099.
28. Cakir S, Dincbas FO, Uzel O: Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiother Oncol 1995, 37:10-16.
29. Kraus DH, Dubner S, Harrison LB, et al.: Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994, 74:697-702.
30. Wanebo HJ, Koness RJ, MacFarlane JK, et al.: Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 1992, 14:1-7.
31. Greager JA, Patel MK, Briele HA, et al.: Soft tissue sarcomas of the adult head and neck. Cancer 1985, 56:820-824.
32. Farhood AI, Hajdu SI, Shiu MH, et al.: Soft tissue sarcomas of the head and neck in adults. Am J Surg 1990, 160:365-369.
33. LeVay J, O'Sullivan B, Catton C, et al.: An assessment of prognostic factors in soft-tissue sarcoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994, 120:981-986.
34. Bowden L, Booher RJ: The principles and technique of resection of soft parts for sarcoma. Surgery 1958, 44:963-976.
35. Enneking WK: Natural history. In Musculoskeletal Tumor Surgery. Edited by Enneking WK. New York: Churchill Livingstone; 1983:1-23.
36. Yang JC, Chang AE, Baker AR, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197-203.
37. Bentz BG, Singh B, Woodruff J, et al.: Head and neck soft tissue sarcomas: A multivariate analysis of outcomes. Ann Surg Oncol 2004, 11:619-628.
38. Harrison LB, Franzese F, Gaynor JJ, et al.: Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys 1993, 27:259-265.
39. Cormier JN, Pollock RE: Soft tissue sarcomas. CA Cancer J Clin 2004, 54:94-109.
40. O'Sullivan B, Davis AM, Turcotte R, et al.: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomized trial. Lancet 2002, 359:2235-2241.
41. O'Sullivan B, Gullane P, Irish J, et al.: Preoperative radiotherapy for adult head and neck soft tissue sarcoma: Assessment of wound complication rates and cancer outcome in a prospective series. World J Surg 2003, 27:875-883.
42. De Paoli A, Bertola G, Boz G, et al.: Radiation therapy and conservative surgery for soft tissue sarcomas of the extremities, torso and head and neck. Ann Oncol 1992, 3(Suppl 2):S97-S101.
43. Clark MA, Fisher C, Judson I, et al.: Soft-tissue sarcomas in adults. N Engl J Med 2005, 353:701-711.
44. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997, 350:1647-1654.
45. Bramwell V, Rouesse J, Steward W, et al.: Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma - reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994, 12: 1137-1149.
46. Meric F, Milas M, Hunt KK, et al.: Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 2000, 18:3378-3383.
47. Pisters PW, Ballo MT, Patel SR: Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol 2002, 9:535-542.
48. Kraybill WG, Spiro IJ, Harris JA, et al.: Radiation Therapy Oncology (RTOG) 95-14: A phase II study of neoadjuvant chemotherapy and radiation therapy in high risk, high grade, soft tissue sarcoma of the extremities and body wall: A preliminary report. Proc Am Soc Clin Oncol 2001, 20:348a.
49. Patel SR, Zagars GK, Pisters PW: The follow-up of adult soft-tissue sarcomas. Semin Oncol 2003, 30:413-416.
50. Maki RG, Wathen JK, Patel SR, et al.: Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patient with metastatic soft tissue sarcomas: Results of Sarcoma Alliance for Research through Collaboration Study 002. J Clin Oncol 2007, 25:2755-2763.
51. Shellenberger TD, SturHis EM: Sarcoma special situations: head and neck. In Advanced Therapy in Surgical Oncology. Edited by Pollock RE, Curley SA, Ross MI, Perrier ND. Hamilton, ON: BC Decker; 2008:707-716.